Embecta Corp.

NASDAQ: EMBC · Real-Time Price · USD
13.71
-0.16 (-1.15%)
At close: Aug 15, 2025, 10:02 AM

Company Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.

Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes.

The company primarily sells its products to wholesalers and distributors in the United States and internationally.

Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.

Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Embecta Corp.
Embecta Corp. logo
Country United States
IPO Date Mar 22, 2022
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,000
CEO Devdatt Kurdikar

Contact Details

Address:
300 Kimball Drive
Parsippany, New Jersey
United States
Website https://www.embecta.com

Stock Details

Ticker Symbol EMBC
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001872789
CUSIP Number 29082K105
ISIN Number US29082K1051
Employer ID 87-1583942
SIC Code 3841

Key Executives

Name Position
Devdatt Kurdikar Ph.D. President, Chief Executive Officer & Director
Colleen Riley Senior Vice President & Chief Technology Officer
Jacob P. Elguicze Senior Vice President & Chief Financial Officer
Anthony M. Roth Vice President, Chief Accounting Officer & Corporate Controller
Ginny Blocki Senior Vice President of Global Marketing & Product Management
Jean M. Casner Senior Vice President & Chief Human Resources Officer
Jeffrey Z. Mann Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary
Pravesh Khandelwal Vice President & Head of Investor Relations
Shaun Curtis Senior Vice President of Global Manufacturing & Supply Chain
Tom Blount Senior Vice President & President of North America

Latest SEC Filings

Date Type Title
Aug 14, 2025 SCHEDULE 13G/A [Amend] Filing
Aug 11, 2025 4 Filing
Aug 08, 2025 10-Q Quarterly Report
Aug 08, 2025 8-K Current Report
Jul 29, 2025 SCHEDULE 13G/A [Amend] Filing
Jul 18, 2025 SCHEDULE 13G/A [Amend] Filing
May 30, 2025 SD Filing
May 23, 2025 4 Filing
May 22, 2025 8-K Current Report
May 15, 2025 SCHEDULE 13G/A [Amend] Filing